Cuu Long Pharmaceutical Joint Stock Company provided earnings guidance for the fiscal year 2022. For the period, the company expects net revenue to be VND 845,510 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,700 VND | 0.00% | -1.37% | +14.80% |
1st Jan change | Capi. | |
---|---|---|
+14.80% | 8.24Cr | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- DCL Stock
- News Cuu Long Pharmaceutical
- Cuu Long Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2022